Education

• B.S. in Pharmacy, West China School of Pharmacy, Sichuan University, 2007-2011
  • GPA: 3.63/ 4.0 (top 1%)
• M.S. in Pharmaceutics, Fudan University, 2011-2014
  • Thesis: Brain-targeted nano-delivery system for treatment of Alzheimer’s disease
  • Supervisor: Prof. Xinguo Jiang (Chief scientist of China 973 Program), Prof. Qizhi Zhang
  • GPA: 3.70/ 4.0 (top 1%)

Work experience

• 2015-Now: Clinical Pharmacist
  • Renji Hospital, Shanghai Jiaotong University
• 2014-2015: Pharmacist
  • Shanghai Children’s medical center, Shanghai Jiaotong University

Research Experience

• 2016-Present Evidence-Based pharmacy, systematic literature review, meta-analysis
  • Focus on the efficacy and safety about anticoagulants (involving warfarin & non-vitamin K antagonist oral anticoagulants)
  • Evaluated the relationship between non-vitamin K antagonist oral anticoagulants and cognitive impairment in atrial fibrillation patients
  • Investigated the risk of renal impairment in atrial fibrillation patients receiving non-vitamin K antagonist oral anticoagulants
  • Reported a case on ticagrelor-induced life-threatening bleeding via drug interaction
• 2011-2018 Brain-targeted nano-delivery system for treatment of Alzheimer’s disease (AD)
  • Developed a dual-functional nanoparticle drug delivery system, for blood-brain barrier transport and Aβ42 targeting. With encapsulation of β-sheet breaker peptide, the delivery system showed good neuroprotective effects on AD model mice. (NSFC No. 81273461)
  • Conducted a brain neuron-targeted nanoparticle gene delivery system for AD treatment. Encapsulated with siRNA drug, the nano-delivery system presented neuroprotective effects on AD model mice. (NSFC No. 81502991)

Honours & Awards

• Academic:
  • National Scholarship (top 1%),
  • First Prize Scholarship for freshmen, Fudan University (top 1%)
  • First Prize Scholarship, Sichuan University (top 1%)
• Social activities:
  • Outstanding graduate cadres, Outstanding student
  • Excellent League member, Excellent individual of the youth volunteer action

Funding

• National Nature Science Foundation of China (NSFC) (No. 81502991，2015-2018): Brain neuron-targeted rHDL nanoparticles in the therapy of Alzheimer’s disease

Publications

Paper Title Number 1

Your Name, You. (2009). "Paper Title Number 1." Journal 1. 1(1).

Paper Title Number 1

Your Name, You. (2009). "Paper Title Number 1." Journal 1. 1(1).

Paper Title Number 1

Your Name, You. (2009). "Paper Title Number 1." Journal 1. 1(1).

Paper Title Number 1

Your Name, You. (2009). "Paper Title Number 1." Journal 1. 1(1).

Paper Title Number 1

Your Name, You. (2009). "Paper Title Number 1." Journal 1. 1(1).

Paper Title Number 1

Your Name, You. (2009). "Paper Title Number 1." Journal 1. 1(1).

Paper Title Number 1

Your Name, You. (2009). "Paper Title Number 1." Journal 1. 1(1).

Paper Title Number 2

Your Name, You. (2010). "Paper Title Number 2." Journal 1. 1(2).

Brain delivery of NAP with PEG-PLGA nanoparticles modified with phage display peptides

Chi Zhang, Jingwei Li, et al., Brain Delivery of NAP with PEG-PLGA Nanoparticles Modified with Phage Display Peptides [J]. Pharm Res,2013 (30):1813-1823.

Dual-functional nanoparticles targeting amyloid plaques in the brains of Alzheimer’s disease mice

Chi Zhang, Xu Wan, et al., Dual-functional nanoparticles targeting amyloid plaques in the brains of Alzheimer’s disease mice [J]. Biomaterials，2014(35):456-465

Paper Title Number 3

Your Name, You. (2015). "Paper Title Number 3." Journal 1. 1(3).